ANAGENICS LIMITED - Announcements

Market Cap $3.690M Add to my watchlist

Consumer Defensive Household & Personal Products

Anagenics Limited is an Australia-based health and beauty-tech company. The Company... Anagenics Limited is an Australia-based health and beauty-tech company. The Company offers a range of clinically validated anti-ageing and wellness products developed in-house or sourced from premium international brands. The Company, through its wholly owned subsidiary Advangen Pty Ltd, develops, manufactures and markets anti-aging products globally, with its FGF5 inhibitor hair health and hair growth products sold worldwide. The flagship anti-aging hair care range, marketed as evolis, Advangen Jo-Ju and Lexilis brands, is sold in Japan, the United States of America and Australia. The Company’s subsidiary is BLC Cosmetics Pty Limited, which is the distributor of international and local skin care and wellbeing brands. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

AN1	Change in substantial holding-CDY.AX		29/06/16	132.41KB	Share
AN1	MIDKINE INTERVIEWS WITH PHARMATELEVISION PUBLISHED-CDY.AX		29/06/16	165.62KB	Share
AN1	Becoming a substantial holder-CDY.AX		28/06/16	137.42KB	Share
AN1	MK antibody publication and patent in bone healing-CDY.AX	PRICE SENSITIVE	24/06/16		Share
AN1	MK antibody publication and patent in bone healing-CDY.AX	PRICE SENSITIVE	24/06/16	113.86KB	Share
AN1	Change of Director's Interest Notice - Halasz-CDY.AX		20/06/16	131.68KB	Share
AN1	CELLMID LAUNCHES EVOLIS PROFESSIONAL PRODUCTS-CDY.AX		14/06/16	86.49KB	Share
AN1	Update on Japanese Sales-CDY.AX		26/05/16	82.65KB	Share
AN1	4th MIDKINE SYMPOSIUM RESULTS-CDY.AX		11/05/16	104.38KB	Share
AN1	Significant Scientific Appointment for Advisory Board Chair-CDY.AX		09/05/16	182.45KB	Share
AN1	Appendix 4C - quarterly-CDY.AX	PRICE SENSITIVE	21/04/16	183KB	Share
AN1	Midkine Strategy Update-CDY.AX	PRICE SENSITIVE	08/04/16	83.56KB	Share
AN1	Fourth Midkine Symposium to be held in Budapest-CDY.AX		04/04/16	97.86KB	Share
AN1	Transcript of Cellmid Investor Briefing		29/02/16	94.78KB	Share
AN1	Cellmid to Refinance RnD Loan	PRICE SENSITIVE	26/02/16	84.44KB	Share
AN1	Appendix 4D and Half Year Accounts	PRICE SENSITIVE	25/02/16	1.68MB	Share
AN1	Cellmid Investor Briefing		23/02/16	97.73KB	Share
AN1	Director Appointment/Resignation		04/02/16	52.85KB	Share
AN1	Appendix 4C - quarterly	PRICE SENSITIVE	27/01/16	151.53KB	Share
AN1	Appendix 3Y - Maria Halasz		18/12/15	57.53KB	Share
AN1	Cellmid receives $1.12M R&D Tax Credit	PRICE SENSITIVE	11/12/15	65.1KB	Share
AN1	Key Antibody Patent Granted in Europe	PRICE SENSITIVE	01/12/15	78.79KB	Share
AN1	Correction in Relation to Date of Announcement		24/11/15	75.33KB	Share
AN1	Japanese Patent granted for use of Midkine for Hair Growth	PRICE SENSITIVE	24/11/15	97.57KB	Share
AN1	Change of Director's Interest Notices		19/11/15	51.76KB	Share
AN1	Appendix 3B		19/11/15	101.69KB	Share
AN1	Results of Meeting		12/11/15	46.64KB	Share
AN1	AGM Presentation to Shareholders		12/11/15	2.03MB	Share
AN1	Company Secretary Appointment/Resignation		30/10/15	58.69KB	Share
AN1	Appendix 4C - quarterly	PRICE SENSITIVE	27/10/15	331.63KB	Share
AN1	Cellmid 2015 Annual Report to Shareholders		12/10/15	2.13MB	Share
AN1	Notice of Annual General Meeting/Proxy Form		12/10/15	330.11KB	Share
AN1	Date of Annual General Meeting		28/09/15	55.38KB	Share
AN1	Cleansing Statement and Appendix 3B		15/09/15	530.36KB	Share
AN1	Results of EGM		09/09/15	73.41KB	Share
AN1	EGM Presentation by CEO		09/09/15	2.79MB	Share
AN1	Appendix 4G and Corporate Governance Statement		31/08/15	535.73KB	Share
AN1	Appendix 4E and Preliminary Final Report	PRICE SENSITIVE	31/08/15	887.57KB	Share
AN1	Cellmid Launching Major Advertising Campaign	PRICE SENSITIVE	27/08/15	163.66KB	Share
AN1	Appendix 3Y - Dr Edward Fintan Walton		13/08/15	20.04KB	Share
AN1	Cellmid appoints EAS to support US Strategy	PRICE SENSITIVE	12/08/15	258.52KB	Share
AN1	Notice of Extraordinary General Meeting/Proxy Form		10/08/15	265.23KB	Share
AN1	CDY Newsletter August 2015		06/08/15	1.13MB	Share
AN1	Cleansing Notice and Appendix 3B		05/08/15	546.46KB	Share
AN1	Appendix 4C - quarterly	PRICE SENSITIVE	30/07/15	335.18KB	Share
AN1	Cellmid raises $4M to leverage sales growth	PRICE SENSITIVE	30/07/15	84.07KB	Share
AN1	Trading Halt	PRICE SENSITIVE	28/07/15	115.25KB	Share
AN1	Appendix 3X - Dr Edward Fintan Walton		23/07/15	9.51KB	Share
AN1	Cellmid Appoints Dr Fintan Walton as Director		21/07/15	140.42KB	Share
AN1	Letter to Shareholders		15/07/15	83.83KB	Share
AN1	Cellmid Revenue Guidance Upgrade	PRICE SENSITIVE	09/07/15	74.32KB	Share
AN1	Dr Bryce Vissel to Chair Cellmid's Scientific Advisory Board		07/07/15	103.11KB	Share
AN1	Initial Director's Interest Notice - B Gordon		01/07/15	185.42KB	Share
AN1	Final Director's Interest Notice - M Rogers		01/07/15	280.57KB	Share
AN1	Final Director's Interest Notice - G Kaufman		01/07/15	344.06KB	Share
AN1	Details of Share Registry address		30/06/15	60.87KB	Share
AN1	US Patent for Anti-Midkine Antibodies Granted	PRICE SENSITIVE	29/06/15	101.52KB	Share
AN1	Cellmid Announces Brain Cancer Program	PRICE SENSITIVE	23/06/15	111.11KB	Share
AN1	Cellmid Invited to Present at Breakfast @ BIO		17/06/15	2.14MB	Share
AN1	Positive Toxicology Study Results for CAB102	PRICE SENSITIVE	15/06/15	103.32KB	Share
AN1	Cellmid Signs Agreement with Maywufa	PRICE SENSITIVE	02/06/15	84.22KB	Share
AN1	Director Appointment / Resignation		26/05/15	64.43KB	Share
AN1	Appendix 3B		19/05/15	517.31KB	Share
AN1	Cellmid Secures $1M Loan Funding	PRICE SENSITIVE	15/05/15	81.03KB	Share
AN1	Appendix 4C - quarterly	PRICE SENSITIVE	29/04/15	325.63KB	Share
AN1	Positive Clinical Results for Cellmid Hair Growth Product	PRICE SENSITIVE	15/04/15	106.11KB	Share
AN1	Cellmid Presenting at World Congress on Angiogenesis		13/04/15	92.52KB	Share
AN1	Company Secretary Appointment/Resignation		31/03/15	58.72KB	Share
AN1	Change of Director's Interest Notice		10/03/15	351.08KB	Share
AN1	NSW Broker Meets Biotech Presentation		04/03/15	639.45KB	Share
AN1	Appendix 4D and Half Year Accounts	PRICE SENSITIVE	24/02/15	1.16MB	Share
AN1	February 2015 Newsletter		11/02/15	1.03MB	Share
AN1	Appendix 4C - quarterly	PRICE SENSITIVE	28/01/15	282.08KB	Share
AN1	USA Patent Granted for Treatment of Heart Failure	PRICE SENSITIVE	21/01/15	88.64KB	Share
AN1	Australian Patent Granted for Use of Midkine for Hair Growth	PRICE SENSITIVE	12/01/15	97.82KB	Share
AN1	Cleansing Notice and Appendix 3B		18/12/14	198.05KB	Share
AN1	Key Midkine Antibody Patent Granted	PRICE SENSITIVE	15/12/14	75.9KB	Share
AN1	Cellmid Capital Raising	PRICE SENSITIVE	15/12/14	72.73KB	Share
AN1	Trading Halt	PRICE SENSITIVE	11/12/14	178.91KB	Share
AN1	Cellmid signs agreement with Zoetis	PRICE SENSITIVE	17/11/14	21.29KB	Share
AN1	Appendix 4C - quarterly	PRICE SENSITIVE	29/10/14	93.21KB	Share
AN1	Results of Annual General Meeting		10/10/14	23.25KB	Share
AN1	AGM Presentation by CEO		10/10/14	1.78MB	Share
AN1	Change of Director's Interest Notice		19/09/14	72.55KB	Share
AN1	Annual Report to shareholders 2014		16/09/14	3.31MB	Share
AN1	Notice of Annual General Meeting and Proxy Form		08/09/14	269.29KB	Share
AN1	Appendix 4E and Preliminary Final Report	PRICE SENSITIVE	29/08/14	406.37KB	Share
AN1	Date of Annual General Meeting		20/08/14	56.23KB	Share
AN1	Cellmid Newsletter		18/08/14	1.47MB	Share
AN1	Cleansing Notice and Appendix 3B		15/08/14	695.58KB	Share
AN1	Appendix 4C - quarterly	PRICE SENSITIVE	29/07/14	91.69KB	Share
AN1	Cellmid Granted UK Patent for Use of Midkine for Hair Growth	PRICE SENSITIVE	16/07/14	29.37KB	Share
AN1	Landmark Study- FGF5 Critical Regulator of Human Hair Growth	PRICE SENSITIVE	15/07/14	31.41KB	Share
AN1	Quest Diagnostic License Update	PRICE SENSITIVE	20/06/14	28.46KB	Share
AN1	Manufacturing Partner Appointed by Cellmid	PRICE SENSITIVE	19/06/14	29.47KB	Share
AN1	Change of Director's Interest Notice - Graeme Kaufman		02/06/14	251.78KB	Share
AN1	Notice of ceasing to be a substantial holder		20/05/14	137.31KB	Share
AN1	Key Milestone Completed, Lead Antibody Selected	PRICE SENSITIVE	07/05/14	29.62KB	Share
AN1	Significant New Findings Presented at 3rd Midkine Symposium	PRICE SENSITIVE	30/04/14	28.98KB	Share
AN1	Appendix 4C - quarterly	PRICE SENSITIVE	28/04/14	90.15KB	Share

AN1 Change in substantial holding-CDY.AX
29/06/16		132.41KB	Share
AN1 MIDKINE INTERVIEWS WITH PHARMATELEVISION PUBLISHED-CDY.AX
29/06/16		165.62KB	Share
AN1 Becoming a substantial holder-CDY.AX
28/06/16		137.42KB	Share
AN1 MK antibody publication and patent in bone healing-CDY.AX
24/06/16	PRICE SENSITIVE		Share
AN1 MK antibody publication and patent in bone healing-CDY.AX
24/06/16	PRICE SENSITIVE	113.86KB	Share
AN1 Change of Director's Interest Notice - Halasz-CDY.AX
20/06/16		131.68KB	Share
AN1 CELLMID LAUNCHES EVOLIS PROFESSIONAL PRODUCTS-CDY.AX
14/06/16		86.49KB	Share
AN1 Update on Japanese Sales-CDY.AX
26/05/16		82.65KB	Share
AN1 4th MIDKINE SYMPOSIUM RESULTS-CDY.AX
11/05/16		104.38KB	Share
AN1 Significant Scientific Appointment for Advisory Board Chair-CDY.AX
09/05/16		182.45KB	Share
AN1 Appendix 4C - quarterly-CDY.AX
21/04/16	PRICE SENSITIVE	183KB	Share
AN1 Midkine Strategy Update-CDY.AX
08/04/16	PRICE SENSITIVE	83.56KB	Share
AN1 Fourth Midkine Symposium to be held in Budapest-CDY.AX
04/04/16		97.86KB	Share
AN1 Transcript of Cellmid Investor Briefing
29/02/16		94.78KB	Share
AN1 Cellmid to Refinance RnD Loan
26/02/16	PRICE SENSITIVE	84.44KB	Share
AN1 Appendix 4D and Half Year Accounts
25/02/16	PRICE SENSITIVE	1.68MB	Share
AN1 Cellmid Investor Briefing
23/02/16		97.73KB	Share
AN1 Director Appointment/Resignation
04/02/16		52.85KB	Share
AN1 Appendix 4C - quarterly
27/01/16	PRICE SENSITIVE	151.53KB	Share
AN1 Appendix 3Y - Maria Halasz
18/12/15		57.53KB	Share
AN1 Cellmid receives $1.12M R&D Tax Credit
11/12/15	PRICE SENSITIVE	65.1KB	Share
AN1 Key Antibody Patent Granted in Europe
01/12/15	PRICE SENSITIVE	78.79KB	Share
AN1 Correction in Relation to Date of Announcement
24/11/15		75.33KB	Share
AN1 Japanese Patent granted for use of Midkine for Hair Growth
24/11/15	PRICE SENSITIVE	97.57KB	Share
AN1 Change of Director's Interest Notices
19/11/15		51.76KB	Share
AN1 Appendix 3B
19/11/15		101.69KB	Share
AN1 Results of Meeting
12/11/15		46.64KB	Share
AN1 AGM Presentation to Shareholders
12/11/15		2.03MB	Share
AN1 Company Secretary Appointment/Resignation
30/10/15		58.69KB	Share
AN1 Appendix 4C - quarterly
27/10/15	PRICE SENSITIVE	331.63KB	Share
AN1 Cellmid 2015 Annual Report to Shareholders
12/10/15		2.13MB	Share
AN1 Notice of Annual General Meeting/Proxy Form
12/10/15		330.11KB	Share
AN1 Date of Annual General Meeting
28/09/15		55.38KB	Share
AN1 Cleansing Statement and Appendix 3B
15/09/15		530.36KB	Share
AN1 Results of EGM
09/09/15		73.41KB	Share
AN1 EGM Presentation by CEO
09/09/15		2.79MB	Share
AN1 Appendix 4G and Corporate Governance Statement
31/08/15		535.73KB	Share
AN1 Appendix 4E and Preliminary Final Report
31/08/15	PRICE SENSITIVE	887.57KB	Share
AN1 Cellmid Launching Major Advertising Campaign
27/08/15	PRICE SENSITIVE	163.66KB	Share
AN1 Appendix 3Y - Dr Edward Fintan Walton
13/08/15		20.04KB	Share
AN1 Cellmid appoints EAS to support US Strategy
12/08/15	PRICE SENSITIVE	258.52KB	Share
AN1 Notice of Extraordinary General Meeting/Proxy Form
10/08/15		265.23KB	Share
AN1 CDY Newsletter August 2015
06/08/15		1.13MB	Share
AN1 Cleansing Notice and Appendix 3B
05/08/15		546.46KB	Share
AN1 Appendix 4C - quarterly
30/07/15	PRICE SENSITIVE	335.18KB	Share
AN1 Cellmid raises $4M to leverage sales growth
30/07/15	PRICE SENSITIVE	84.07KB	Share
AN1 Trading Halt
28/07/15	PRICE SENSITIVE	115.25KB	Share
AN1 Appendix 3X - Dr Edward Fintan Walton
23/07/15		9.51KB	Share
AN1 Cellmid Appoints Dr Fintan Walton as Director
21/07/15		140.42KB	Share
AN1 Letter to Shareholders
15/07/15		83.83KB	Share
AN1 Cellmid Revenue Guidance Upgrade
09/07/15	PRICE SENSITIVE	74.32KB	Share
AN1 Dr Bryce Vissel to Chair Cellmid's Scientific Advisory Board
07/07/15		103.11KB	Share
AN1 Initial Director's Interest Notice - B Gordon
01/07/15		185.42KB	Share
AN1 Final Director's Interest Notice - M Rogers
01/07/15		280.57KB	Share
AN1 Final Director's Interest Notice - G Kaufman
01/07/15		344.06KB	Share
AN1 Details of Share Registry address
30/06/15		60.87KB	Share
AN1 US Patent for Anti-Midkine Antibodies Granted
29/06/15	PRICE SENSITIVE	101.52KB	Share
AN1 Cellmid Announces Brain Cancer Program
23/06/15	PRICE SENSITIVE	111.11KB	Share
AN1 Cellmid Invited to Present at Breakfast @ BIO
17/06/15		2.14MB	Share
AN1 Positive Toxicology Study Results for CAB102
15/06/15	PRICE SENSITIVE	103.32KB	Share
AN1 Cellmid Signs Agreement with Maywufa
02/06/15	PRICE SENSITIVE	84.22KB	Share
AN1 Director Appointment / Resignation
26/05/15		64.43KB	Share
AN1 Appendix 3B
19/05/15		517.31KB	Share
AN1 Cellmid Secures $1M Loan Funding
15/05/15	PRICE SENSITIVE	81.03KB	Share
AN1 Appendix 4C - quarterly
29/04/15	PRICE SENSITIVE	325.63KB	Share
AN1 Positive Clinical Results for Cellmid Hair Growth Product
15/04/15	PRICE SENSITIVE	106.11KB	Share
AN1 Cellmid Presenting at World Congress on Angiogenesis
13/04/15		92.52KB	Share
AN1 Company Secretary Appointment/Resignation
31/03/15		58.72KB	Share
AN1 Change of Director's Interest Notice
10/03/15		351.08KB	Share
AN1 NSW Broker Meets Biotech Presentation
04/03/15		639.45KB	Share
AN1 Appendix 4D and Half Year Accounts
24/02/15	PRICE SENSITIVE	1.16MB	Share
AN1 February 2015 Newsletter
11/02/15		1.03MB	Share
AN1 Appendix 4C - quarterly
28/01/15	PRICE SENSITIVE	282.08KB	Share
AN1 USA Patent Granted for Treatment of Heart Failure
21/01/15	PRICE SENSITIVE	88.64KB	Share
AN1 Australian Patent Granted for Use of Midkine for Hair Growth
12/01/15	PRICE SENSITIVE	97.82KB	Share
AN1 Cleansing Notice and Appendix 3B
18/12/14		198.05KB	Share
AN1 Key Midkine Antibody Patent Granted
15/12/14	PRICE SENSITIVE	75.9KB	Share
AN1 Cellmid Capital Raising
15/12/14	PRICE SENSITIVE	72.73KB	Share
AN1 Trading Halt
11/12/14	PRICE SENSITIVE	178.91KB	Share
AN1 Cellmid signs agreement with Zoetis
17/11/14	PRICE SENSITIVE	21.29KB	Share
AN1 Appendix 4C - quarterly
29/10/14	PRICE SENSITIVE	93.21KB	Share
AN1 Results of Annual General Meeting
10/10/14		23.25KB	Share
AN1 AGM Presentation by CEO
10/10/14		1.78MB	Share
AN1 Change of Director's Interest Notice
19/09/14		72.55KB	Share
AN1 Annual Report to shareholders 2014
16/09/14		3.31MB	Share
AN1 Notice of Annual General Meeting and Proxy Form
08/09/14		269.29KB	Share
AN1 Appendix 4E and Preliminary Final Report
29/08/14	PRICE SENSITIVE	406.37KB	Share
AN1 Date of Annual General Meeting
20/08/14		56.23KB	Share
AN1 Cellmid Newsletter
18/08/14		1.47MB	Share
AN1 Cleansing Notice and Appendix 3B
15/08/14		695.58KB	Share
AN1 Appendix 4C - quarterly
29/07/14	PRICE SENSITIVE	91.69KB	Share
AN1 Cellmid Granted UK Patent for Use of Midkine for Hair Growth
16/07/14	PRICE SENSITIVE	29.37KB	Share
AN1 Landmark Study- FGF5 Critical Regulator of Human Hair Growth
15/07/14	PRICE SENSITIVE	31.41KB	Share
AN1 Quest Diagnostic License Update
20/06/14	PRICE SENSITIVE	28.46KB	Share
AN1 Manufacturing Partner Appointed by Cellmid
19/06/14	PRICE SENSITIVE	29.47KB	Share
AN1Change of Director's Interest Notice - Graeme Kaufman
02/06/14		251.78KB	Share
AN1Notice of ceasing to be a substantial holder
20/05/14		137.31KB	Share
AN1Key Milestone Completed, Lead Antibody Selected
07/05/14	PRICE SENSITIVE	29.62KB	Share
AN1Significant New Findings Presented at 3rd Midkine Symposium
30/04/14	PRICE SENSITIVE	28.98KB	Share
AN1Appendix 4C - quarterly
28/04/14	PRICE SENSITIVE	90.15KB	Share